WHO Urges Universal Monkeypox Fight 30/08/2022 John Heilprin The World Health Organization’s top official in Europe says the monkeypox outbreak appears to be slowing in the region, and could be eliminated through universal effort. “There are encouraging early signs, as evidenced in France, Germany, Portugal, Spain, the U.K., and other countries, that the outbreak may be slowing,” WHO’s Regional Director for Europe Dr […] Continue reading -> WHO Lists Entities That Can Engage with Pandemic Treaty Negotiating Body 29/08/2022 Kerry Cullinan A wide range of groups including civil society, academic and health groups have been identified as stakeholders that are able to interact with the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB) on a pandemic preparedness instrument. The WHO published the list last week but stressed that it was a “living document with further possibilities […] Continue reading -> How to Know if You Should Work in Global Health 27/08/2022 Editorial team For emerging global health professionals from the world’s “south,” choosing whether to focus their energy on local issues or on international challenges is always a dilemma, Chief Planetary Health Scientist of Sunway Centre for Planetary Health in Malaysia Renzo Guinto argues. “One important crossroad that I’ve encountered is tension on whether I stay in the […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Lists Entities That Can Engage with Pandemic Treaty Negotiating Body 29/08/2022 Kerry Cullinan A wide range of groups including civil society, academic and health groups have been identified as stakeholders that are able to interact with the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB) on a pandemic preparedness instrument. The WHO published the list last week but stressed that it was a “living document with further possibilities […] Continue reading -> How to Know if You Should Work in Global Health 27/08/2022 Editorial team For emerging global health professionals from the world’s “south,” choosing whether to focus their energy on local issues or on international challenges is always a dilemma, Chief Planetary Health Scientist of Sunway Centre for Planetary Health in Malaysia Renzo Guinto argues. “One important crossroad that I’ve encountered is tension on whether I stay in the […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How to Know if You Should Work in Global Health 27/08/2022 Editorial team For emerging global health professionals from the world’s “south,” choosing whether to focus their energy on local issues or on international challenges is always a dilemma, Chief Planetary Health Scientist of Sunway Centre for Planetary Health in Malaysia Renzo Guinto argues. “One important crossroad that I’ve encountered is tension on whether I stay in the […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa Has Not Received a Single Dose of Monkeypox Vaccine – Even Though Virus is Endemic and Often More Deadly 25/08/2022 Paul Adepoju Another COVID rerun: WHO and Africa CDC officials lament the complete lack of access to monkeypox vaccines on the continent where the virus is endemic – as well as often more deadly than elsewhere. Meanwhile, Mozambique and Malawi have seen a total of six wild poliovirus cases, although WHO officials continue to insist that since […] Continue reading -> Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Monkeypox Cases Drop 21% Globally As WHO Weighs ‘Fractional’ Vaccine Dose Strategy 25/08/2022 John Heilprin The global number of weekly new cases of monkeypox reported to the World Health Organization (WHO) declined by 21% for the first time since the infection that has been endemic to central and west Africa began to appear around the world earlier this year. Cases continued rising sharply in the Americas, however, in contrast to […] Continue reading -> Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Chronic Disease Focus of New Strategy 25/08/2022 Paul Adepoju Ministers and government officials took on noncommunicable diseases, sickle cell disease, health system reforms in response to the COVID-19 pandemic, and measures to fight tuberculosis among children in Africa during their meeting of the 72nd WHO Regional Committee for Africa this week. In an effort to curb Africa’s chronic disease crisis, African health ministers adopted […] Continue reading -> NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death by 81% in Older Adults, Not Effective in Younger Patients 24/08/2022 Maayan Hoffman Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading -> Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Submits Reguest to US FDA for Approval of Omicron-targeted COVID Booster Shot 23/08/2022 Zachary Brennan, via Endpoints News The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading -> Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Monkeypox Vaccine: 62% of Recipients Experience No Side Effects, Says New Survey 22/08/2022 Maayan Hoffman A first-of-its-kind survey examining the side effects of the monkeypox vaccine in Israel found that the majority of recipients had no general symptoms. “Most of the side effects reported by the vaccinated are local and mild, which in most cases pass within one to three days,” said Miri Mizrahi Reuveni, Deputy CEO and Head of […] Continue reading -> Posts navigation Older postsNewer posts